ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HIK Hikma Pharmaceuticals Plc

1,934.00
-20.00 (-1.02%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -1.02% 1,934.00 1,925.00 1,926.00 1,956.00 1,919.00 1,955.00 145,039 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 22.25 4.34B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,954p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,722.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.34 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.25.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1626 to 1647 of 1875 messages
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older
DateSubjectAuthorDiscuss
25/5/2022
07:20
JPM cuts to neutral from overweight.
sza2002
25/5/2022
07:09
Surely a TO target now one wld think
scepticalinvestor
24/5/2022
19:31
Wonder why the rns wasn't better worded then.
Suet

suetballs
24/5/2022
19:17
You're right.
Probably the best man to turn things around - and still fairly young at 65.
Suet

suetballs
24/5/2022
19:06
I stand corrected there's a news article saying they are searching for a new ceo apologies
dartboard1
24/5/2022
18:50
They didn't say interim ... rns said he will assume ceo responsibilities ... no mention of searching for new ceo
dartboard1
24/5/2022
18:33
Yes but he’ll only be temporary.
Suet

suetballs
24/5/2022
18:31
The new ceo is the large shareholder
dartboard1
24/5/2022
17:54
Probably under pressure by large shareholders to get someone new in.
montyhedge
24/5/2022
17:02
Just maybe ‘getting rid’ of the ceo will see an improvement in fortunes here. Hope so.
Suet

suetballs
24/5/2022
14:26
Could be worst could be in Nasdaq tech stocks.
montyhedge
24/5/2022
14:13
PS But don’t forget the dividend LMFAO!!
blue59
24/5/2022
08:08
Good news, get someone more dynamic and get the shareprice going.Astra boss would be good, lol.
montyhedge
24/5/2022
07:53
I suspect the indifferent share price performance had something to do with it.
Prompt resignation - no replacement in the wings - indicates disagreements to me.
Suet

suetballs
24/5/2022
06:57
It was prob time tbh
scepticalinvestor
24/5/2022
06:46
Well at least they can treat themselves every time they shoot themselves in the foot.
blue59
24/5/2022
06:26
Not sure too. He was good at Teva and Hikma price rose after he joined.
robertball
24/5/2022
06:23
Not sure abt that, but will be adding a shot load if so
scepticalinvestor
24/5/2022
06:22
Probably 1584 at the open?
sza2002
24/5/2022
06:10
Good riddance, markets will like that i think
scepticalinvestor
20/5/2022
15:27
That’s the 5th time you’ve repeated it! It doesn’t make it any more relevant!!!
blue59
20/5/2022
09:33
I'll go with Barclays recent 2800p target, not your 1600p, lol.
montyhedge
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older